\BOOKMARK [0][-]{chapter.4}{Synthetic Lethal Analysis of Gene Expression Data}{}% 118
\BOOKMARK [1][-]{section.4.1}{Synthetic lethal genes in breast cancer}{chapter.4}% 119
\BOOKMARK [2][-]{subsection.4.1.1}{Synthetic lethal pathways in breast cancer}{section.4.1}% 120
\BOOKMARK [2][-]{subsection.4.1.2}{Expression profiles of synthetic lethal partners}{section.4.1}% 121
\BOOKMARK [3][-]{subsubsection.4.1.2.1}{Subgroup pathway analysis}{subsection.4.1.2}% 122
\BOOKMARK [1][-]{section.4.2}{Comparison of synthetic lethal gene candidates}{chapter.4}% 123
\BOOKMARK [2][-]{subsection.4.2.1}{Comparison with differential expression}{section.4.2}% 124
\BOOKMARK [2][-]{subsection.4.2.2}{Comparison with primary siRNA screen candidates}{section.4.2}% 125
\BOOKMARK [3][-]{subsubsection.4.2.2.1}{Comparison with correlation}{subsection.4.2.2}% 126
\BOOKMARK [3][-]{subsubsection.4.2.2.2}{Comparison with viability}{subsection.4.2.2}% 127
\BOOKMARK [3][-]{subsubsection.4.2.2.3}{Comparison of screen at pathway level}{subsection.4.2.2}% 128
\BOOKMARK [4][-]{subsubsubsection.4.2.2.3.1}{Resampling of genes for pathway enrichment}{subsubsection.4.2.2.3}% 129
\BOOKMARK [2][-]{subsection.4.2.3}{Comparison with secondary screen siRNA screen candidates}{section.4.2}% 130
\BOOKMARK [3][-]{subsubsection.4.2.3.1}{Comparison of candidate SL Pathways}{subsection.4.2.3}% 131
\BOOKMARK [1][-]{section.4.3}{Mutation, Copy Number, and Methylation}{chapter.4}% 132
\BOOKMARK [2][-]{subsection.4.3.1}{Synthetic lethality by DNA copy number}{section.4.3}% 133
\BOOKMARK [2][-]{subsection.4.3.2}{Synthetic lethality by somatic mutation}{section.4.3}% 134
\BOOKMARK [3][-]{subsubsection.4.3.2.1}{Mutation analysis}{subsection.4.3.2}% 135
\BOOKMARK [2][-]{subsection.4.3.3}{ANOVA of Expression Predictors}{section.4.3}% 136
\BOOKMARK [1][-]{section.4.4}{Global Synthetic Lethality}{chapter.4}% 137
\BOOKMARK [2][-]{subsection.4.4.1}{Hub Genes}{section.4.4}% 138
\BOOKMARK [1][-]{section.4.5}{Metagene Analysis}{chapter.4}% 139
\BOOKMARK [2][-]{subsection.4.5.1}{Pathway expression}{section.4.5}% 140
\BOOKMARK [2][-]{subsection.4.5.2}{Somatic mutation}{section.4.5}% 141
\BOOKMARK [2][-]{subsection.4.5.3}{Synthetic lethal metagenes}{section.4.5}% 142
\BOOKMARK [1][-]{section.4.6}{Replication in stomach cancer}{chapter.4}% 143
\BOOKMARK [1][-]{section.4.7}{Replication in cell line encyclopaedia}{chapter.4}% 144
\BOOKMARK [1][-]{section.4.8}{Summary}{chapter.4}% 145
\BOOKMARK [0][-]{section.4.8}{References}{}% 171
